Schizophrenia Clinical Trial
— tACSOfficial title:
Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation
Verified date | January 2021 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The proposed study aims to use a form of neuromodulation, known as transcranial alternating current stimulation (tACS), to improve the effectiveness of the metacognitive training (MCT) program for treatment of delusions in schizophrenia. tACS is a non-invasive brain stimulation method utilizing weak electrical currents applied to the head to influence neural firing (Antal & Paulus, 2013). Brain regions implicated in delusional thinking will be targeted in the hopes of promoting thinking patterns that will allow participants to question delusional beliefs, reducing the severity of delusions and increasing the positive effects of MCT (Whitman et al., in press; Whitman, Minz & Woodward, 2013). Electroencephalogram (EEG) and behavioural assessments will be used to measure treatment effects. However, before tACS will be administered to individuals experiencing delusions associated with schizophrenia we will conduct various control-phase (pilot) studies to gain a better understanding on how tACS temporarily alters performance on cognitive processes by biasing dominant patterns of oscillations. The objective of the pilot studies is to establish the effectiveness of the EGI GTEN system in modulating brain oscillations in the cortex of healthy participants by means of transcranial alternating current stimulation (tACS). In this control/pilot phase of our study, we aim to establish that we can induce changes in the power of a specific frequency band in targeted cortical regions with neuromodulation using the GTEN system, and we will assess whether doing so temporarily alters performance on simple cognitive and perceptual processes in healthy controls. This will be the first step towards translating our stimulation protocol to the patient population for our primary study of interest (tACS as an adjunct to metacognitive training for delusions in psychosis).
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 15, 2020 |
Est. primary completion date | December 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 60 Years |
Eligibility | Inclusion Criteria: - Patients between the ages of 19 to 60 years with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, psychosis not otherwise specified, or a mood disorder with psychotic features will be recruited for this study. Exclusion Criteria: - An inability to read and write in English. Participants must be have used English on a daily basis for at least 5 years, and must be able to understand the consent form and give written consent. - Participants with an IQ score of 80 or lower. - A history of severe neurological disorder and those with severe manifestations of hostility, megalomania, formal thought disorder and suspiciousness will also be excluded from the analysis. - Subjects who are consistently disrupting the treatment group might be asked to leave, this will be at the discretion of the group instructor. - A history of neurological problems (e.g., stroke, aneurysm, Parkinson's, Multiple Sclerosis, encephalitis, meningitis, etc.) - History of seizure disorder or family history of seizure disorder. - History of migraines or other types of frequent severe headaches. - Metallic implants in head. - Severe head injury, frequent loss of consciousness and/or loss of consciousness greater than 30 minutes. - Recently suffered a serious concussion - Pregnancy - Very fatigued and/or recently experienced severe sleep disturbances - Medication known to increase risk of stroke and/or seizure. - Suffer from severe current substance dependence - Have a psychosis that is a direct consequence of substance abuse For control-phase studies: Subjects. We will recruit 440 participants total in the "Enhancement of Treatment of Delusions in Schizophrenia through Neuromodulation" study H16-01791; The current protocol describes the methods to be used in the Control Phase of our research, during which we will recruit 290 healthy controls between 19 and 60 years in order to establish proof-of-concept for using GTEN tACS in modulating brain oscillations and performance on simple cognitive tasks. Exclusion criteria for healthy controls: - history of neurological problems (e.g., stroke, aneurysm, Parkinson's, Multiple Sclerosis, encephalitis, meningitis, etc.) - History of seizure disorder or family history of seizure disorder. While there is no direct evidence to suggest that tACS increases the risk of seizure in those with a history of seizure disorder in their family, research in this area is still relatively recent (< 15 years). Given the unlikely potential for an unknown elevated risk of seizure, we are including this as a conservative precautionary exclusion factor. - History of migraines or other types of frequent severe headaches. tACS can induce a headache in those prone to migraines and other forms of severe headaches. - Presence of metallic implants in head. - History of severe head injury, frequent loss of consciousness and/or loss of consciousness greater than 30 minutes. - Recent history of a serious concussion - Current pregnancy. - Symptoms of severe fatigued and/or recent experience of severe sleep disturbance. - Medication known to increase risk of stroke and/or seizure |
Country | Name | City | State |
---|---|---|---|
Canada | UBC Hospital - Detwiller Pavilion | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia | Brain & Behavior Research Foundation, Vancouver Coastal Health Research Institute |
Canada,
Andreasen NC, Arndt S, Miller D, Flaum M, Nopoulos P. Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update. Psychopathology. 1995;28(1):7-17. Review. — View Citation
Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl. 1989 Nov;(7):49-58. Review. — View Citation
Antal A, Paulus W. Transcranial alternating current stimulation (tACS). Front Hum Neurosci. 2013 Jun 28;7:317. doi: 10.3389/fnhum.2013.00317. Print 2013. — View Citation
Bokil H, Andrews P, Kulkarni JE, Mehta S, Mitra PP. Chronux: a platform for analyzing neural signals. J Neurosci Methods. 2010 Sep 30;192(1):146-51. doi: 10.1016/j.jneumeth.2010.06.020. Epub 2010 Jul 15. — View Citation
Cohen J. A power primer. Psychol Bull. 1992 Jul;112(1):155-9. — View Citation
Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004 Mar 15;134(1):9-21. — View Citation
Dmochowski JP, Koessler L, Norcia AM, Bikson M, Parra LC. Optimal use of EEG recordings to target active brain areas with transcranial electrical stimulation. Neuroimage. 2017 Aug 15;157:69-80. doi: 10.1016/j.neuroimage.2017.05.059. Epub 2017 May 31. — View Citation
Drewes J, VanRullen R. This is the rhythm of your eyes: the phase of ongoing electroencephalogram oscillations modulates saccadic reaction time. J Neurosci. 2011 Mar 23;31(12):4698-708. doi: 10.1523/JNEUROSCI.4795-10.2011. — View Citation
Fernández-Corazza M, Turovets S, Luu P, Anderson E, Tucker D. Transcranial Electrical Neuromodulation Based on the Reciprocity Principle. Front Psychiatry. 2016 May 27;7:87. doi: 10.3389/fpsyt.2016.00087. eCollection 2016. — View Citation
Galambos R, Makeig S, Talmachoff PJ. A 40-Hz auditory potential recorded from the human scalp. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2643-7. — View Citation
Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999 Jul;29(4):879-89. — View Citation
Junghöfer M, Elbert T, Tucker DM, Rockstroh B. Statistical control of artifacts in dense array EEG/MEG studies. Psychophysiology. 2000 Jul;37(4):523-32. — View Citation
Kasten FH, Herrmann CS. Transcranial Alternating Current Stimulation (tACS) Enhances Mental Rotation Performance during and after Stimulation. Front Hum Neurosci. 2017 Jan 31;11:2. doi: 10.3389/fnhum.2017.00002. eCollection 2017. — View Citation
Liddle PF, Ngan ET, Duffield G, Kho K, Warren AJ. Signs and Symptoms of Psychotic Illness (SSPI): a rating scale. Br J Psychiatry. 2002 Jan;180:45-50. — View Citation
Moritz S, Veckenstedt R, Andreou C, Bohn F, Hottenrott B, Leighton L, Köther U, Woodward TS, Treszl A, Menon M, Schneider BC, Pfueller U, Roesch-Ely D. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial. JAMA Psychiatry. 2014 Oct;71(10):1103-11. doi: 10.1001/jamapsychiatry.2014.1038. — View Citation
Moritz S, Veckenstedt R, Randjbar S, Vitzthum F, Woodward TS. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol Med. 2011 Sep;41(9):1823-32. doi: 10.1017/S0033291710002618. Epub 2011 Jan 28. — View Citation
Moritz S, Woodward TS. Jumping to conclusions in delusional and non-delusional schizophrenic patients. Br J Clin Psychol. 2005 Jun;44(Pt 2):193-207. — View Citation
Moritz S, Woodward TS. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr Opin Psychiatry. 2007 Nov;20(6):619-25. Review. — View Citation
Moritz, S., Veckenstedt, R., Vitzthuma, F., Köthera, U., & Woodward,T.S., Metacognitive training in schizophrenia. Theoretical rationale and administration, in Social Cognition In Schizophrenia: From Evidence to Treatment, David L. Roberts and D.L. Penn, Editors. 2013, Oxford University Press: Oxford. p. 358-383.
Ozen S, Sirota A, Belluscio MA, Anastassiou CA, Stark E, Koch C, Buzsáki G. Transcranial electric stimulation entrains cortical neuronal populations in rats. J Neurosci. 2010 Aug 25;30(34):11476-85. doi: 10.1523/JNEUROSCI.5252-09.2010. — View Citation
Parker DA, Hamm JP, McDowell JE, Keedy SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 Jul;209:218-226. doi: 10.1016/j.schres.2019.04.014. Epub 2019 May 9. — View Citation
Rjosk V, Kaminski E, Hoff M, Gundlach C, Villringer A, Sehm B, Ragert P. Transcranial Alternating Current Stimulation at Beta Frequency: Lack of Immediate Effects on Excitation and Interhemispheric Inhibition of the Human Motor Cortex. Front Hum Neurosci. 2016 Nov 3;10:560. eCollection 2016. — View Citation
Sanford N, Lecomte T, Leclerc C, Wykes T, Woodward TS. Change in jumping to conclusions linked to change in delusions in early psychosis. Schizophr Res. 2013 Jun;147(1):207-208. doi: 10.1016/j.schres.2013.02.042. Epub 2013 Apr 3. — View Citation
Speechley WJ, Whitman JC, Woodward TS. The contribution of hypersalience to the "jumping to conclusions" bias associated with delusions in schizophrenia. J Psychiatry Neurosci. 2010 Jan;35(1):7-17. — View Citation
Vosskuhl J, Strüber D, Herrmann CS. Non-invasive Brain Stimulation: A Paradigm Shift in Understanding Brain Oscillations. Front Hum Neurosci. 2018 May 25;12:211. doi: 10.3389/fnhum.2018.00211. eCollection 2018. Review. — View Citation
Whitman JC, Takane Y, Cheung TPL, Moiseev A, Ribary U, Ward LM, Woodward TS. Acceptance of evidence-supported hypotheses generates a stronger signal from an underlying functionally-connected network. Neuroimage. 2016 Feb 15;127:215-226. doi: 10.1016/j.neuroimage.2015.12.011. Epub 2015 Dec 15. — View Citation
Whitman JC, Ward LM, Woodward TS. Patterns of Cortical Oscillations Organize Neural Activity into Whole-Brain Functional Networks Evident in the fMRI BOLD Signal. Front Hum Neurosci. 2013 Mar 14;7:80. doi: 10.3389/fnhum.2013.00080. eCollection 2013. — View Citation
Woodward TS, Jung K, Hwang H, Yin J, Taylor L, Menon M, Peters E, Kuipers E, Waters F, Lecomte T, Sommer IE, Daalman K, van Lutterveld R, Hubl D, Kindler J, Homan P, Badcock JC, Chhabra S, Cella M, Keedy S, Allen P, Mechelli A, Preti A, Siddi S, Erickson D. Symptom dimensions of the psychotic symptom rating scales in psychosis: a multisite study. Schizophr Bull. 2014 Jul;40 Suppl 4:S265-74. doi: 10.1093/schbul/sbu014. — View Citation
Woodward TS, Munz M, LeClerc C, Lecomte T. Change in delusions is associated with change in "jumping to conclusions". Psychiatry Res. 2009 Dec 30;170(2-3):124-7. doi: 10.1016/j.psychres.2008.10.020. Epub 2009 Nov 10. — View Citation
Zaehle T, Rach S, Herrmann CS. Transcranial alternating current stimulation enhances individual alpha activity in human EEG. PLoS One. 2010 Nov 1;5(11):e13766. doi: 10.1371/journal.pone.0013766. — View Citation
Zhang C, Paolozza A, Tseng PH, Reynolds JN, Munoz DP, Itti L. Detection of Children/Youth With Fetal Alcohol Spectrum Disorder Through Eye Movement, Psychometric, and Neuroimaging Data. Front Neurol. 2019 Feb 18;10:80. doi: 10.3389/fneur.2019.00080. eCollection 2019. — View Citation
* Note: There are 31 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Psychotic Symptom Rating Scale | Delusion severity will be measured using the Delusions Scale of the Psychotic Symptom Rating Scales (PSYRATS; Haddock, McCarron, Tarrier, & Faragher, 1999). The PSYRATS Delusion Scale measures specific aspects of delusions such as conviction and impact on thinking. | 8 weeks post-treatment | |
Secondary | Scale for the Assessment of Negative Symptoms | General psychopathology will be assessed using the Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1984). | 8 weeks post-treatment | |
Secondary | Scale for the Assessment of Positive Symptoms | General psychopathology will be assessed using the Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984). | 8 weeks post-treatment | |
Secondary | Signs and Symptoms of Psychotic Illness | General psychopathology will be assessed using the Signs and Symptoms of Psychotic Illness (SSPI; Liddle et al., 2002). | 8 weeks post-treatment | |
Secondary | Jumping to Conclusions Task | A cognitive biases commonly associated with delusions in schizophrenia will be evaluated using the "jumping to conclusions (JTC) task" (also known as the "fish task"). This task will be carried out on computer tablets. These tasks were developed, in part, by the principal investigator and have been described in previous research (Lecomte & Woodward 2005; Woodward 2006a; Woodward 2006b; Woodward 2007; Moritz & Woodward 2005; Woodward 2009). | 8 weeks post-treatment | |
Secondary | Bias Against Disconfirmatory Evidence Task | A cognitive biases commonly associated with delusions in schizophrenia will be evaluated using the "bias against disconfirmatory evidence (BADE) task". This task will be carried out on computer tablets. These tasks were developed, in part, by the principal investigator and have been described in previous research (Lecomte & Woodward 2005; Woodward 2006a; Woodward 2006b; Woodward 2007; Moritz & Woodward 2005; Woodward 2009). | 8 weeks post-treatment | |
Secondary | Electroencephalography Reasoning Bias (Evidence Matching Tasks) | Subjects will be assessed using electroencephalography (EEG) while they complete tasks in which they must determine whether two pieces of information match, in order to quantify the reactivity of the neural networks believed to be responsible for evidence matching (e.g., anterior-cingulate-based network) and integration of disconfirmatory evidence (bilateral prefrontal-based network). These cognitive bias tasks are the "jumping to conclusions task" (or "fish task") and the "bias against disconfirmatory evidence task" previously described, and were developed in part by the principal investigator. | 8 weeks post-treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |